Literature DB >> 17904085

Are racial differences in antihypertensive responsiveness reflected in usage after stroke?

Bruce Ovbiagele1, Nancy K Hills, Jeffrey L Saver, S Claiborne Johnston.   

Abstract

OBJECTIVE: We sought to evaluate whether differential antihypertensive responsiveness in blacks is reflected in discharge antihypertensive prescription patterns among patients hospitalized with an ischemic cerebrovascular event.
METHODS: We analyzed use of discharge antihypertensive medications among patients hospitalized with an ischemic cerebrovascular event in the California Acute Stroke Prototype Registry, examining rates in black patients compared with all other races combined. Generalized estimating equations were used to identify factors independently associated with receipt of any antihypertensive medication overall and with use of specific types of antihypertensives.
RESULTS: Data were collected on 794 consecutive patients treated at 11 hospitals. No significant differences were observed between rates of antihypertensive use in black patients (74%) when compared with all others (69%), either for overall use or for any specific category of antihypertensive, although there was a trend toward more frequent use of diuretics in black patients (P = .12). Results were similar when analysis was limited to those with a history of hypertension.
CONCLUSIONS: In spite of a known differential response to antihypertensives in blacks, we found no differences in discharge antihypertensive prescription patterns in black patients hospitalized with transient ischemic attack and ischemic stroke compared with other races.

Entities:  

Year:  2006        PMID: 17904085      PMCID: PMC2151475          DOI: 10.1016/j.jstrokecerebrovasdis.2006.06.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  31 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Cerebrovascular disease in African Americans.

Authors:  P B Gorelick
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

3.  Hypertension in African Americans: evaluation and treatment issues.

Authors:  S H Kailani; J T Wright
Journal:  J Assoc Acad Minor Phys       Date:  1991

4.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

Review 5.  Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes.

Authors:  James P Stansbury; Huanguang Jia; Linda S Williams; W Bruce Vogel; Pamela W Duncan
Journal:  Stroke       Date:  2005-01-06       Impact factor: 7.914

6.  Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association.

Authors:  P A Wolf; G P Clagett; J D Easton; L B Goldstein; P B Gorelick; M Kelly-Hayes; R L Sacco; J P Whisnant
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

7.  Factors influencing admission blood pressure levels in patients with acute stroke.

Authors:  B Carlberg; K Asplund; E Hägg
Journal:  Stroke       Date:  1991-04       Impact factor: 7.914

8.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeff Mahon; Richard Lewanczuk; Kelly B Zarnke; Brenda Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

10.  Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.

Authors:  Stevo Julius; Michael H Alderman; Gareth Beevers; Björn Dahlöf; Richard B Devereux; Janice G Douglas; Jonathan M Edelman; Katherine E Harris; Sverre E Kjeldsen; Shawna Nesbitt; Otelio S Randall; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.